Novo Nordisk’s Legal Blitz Backfires: Court Tosses Wegovy Knockoff Suit, Pharmacy Seeks $439K in Fees
In a courtroom turnabout, Danish pharmaceutical powerhouse Novo Nordisk has found itself on the losing side of a lawsuit it filed to protect the monopoly of its blockbuster drugs, Wegovy and Ozempic. Now, a Florida pharmacy it targeted is demanding the company cough up nearly half a million dollars in legal fees. Brooksville Pharmaceuticals, the …











